Clinical Laserthermia Systems and Unio Health Partners in the US Announce Clinical Study
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announced it has entered into an agreement with Unio Health Partners to conduct a Phase I clinical study titled “Micro Ultra-Sound Guided Focal Laser Ablation of Low to Intermediate Risk Prostate Cancer”.The study recently received IRB approval from the FDA and will utilize CLS’s TRANBERG® Thermal Therapy System for image-guided focal laser ablation in conjunction with Exact Imaging’s ExactVu™ micro-ultrasound platform to visualize and target areas of interest in the prostate. The TRANBERG system will